Siemens Healthcare Chooses Cologne As The New Site For Its Molecular Diagnostics Rese

[News]

Siemens Healthcare has established new research laboratories for molecular diagnostics in Cologne, Germany. The focus of the research will be on "breast cancer", a disease that remains the number one cause of death among young women despite the large number of therapies currently available.

More... (http://www.medicalnewstoday.com/articles/110054.php)